Intra-Cellular Therapies (ITCI): Director Riggs Rory B was granted 262 shares, increasing direct ownership by 0.22% to 116,862 units (SEC Form 4)
Stocks in this Quantisnow insightHealth Care
Quantisnow market dataNASDAQ
ITCI
Intra-Cellular Therapies Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Get push alerts for ITCI
Full ITCI profile on Quantisnow Follow ITCI and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time